The overall goals of the Clinical Core are to recruit and follow well-characterized research subjects: to support research projects associated with the JHMI ADRC, to provide clinical data and clinical resources to investigators associated with the JHMI ADRC (e.g., brain tissue, DMA, CSF), to conduct collaborative clinical research with other ADCs (including clinical trials), and to provide clinical data to the NACC to further interdisciplinary research in AD. In order to accomplish these goals, the staff of the Clinical Core will continue to follow subjects recruited in the past funding cycle. These subjects consist of two cohorts: (1) the Clinic Cohort (i.e., subjects recruited through the Clinics at JHMI) and (2) the BLSA Cohort (i.e., subjects recruited through the Baltimore Longitudinal Study on Aging). In addition, in the next funding cycle, the Clinical Core will recruit additional subjects including: (1) elderly normal controls, (2) subjects who meet criteria for Mild Cognitive Impairment (MCI), (3) and patients with mild AD. The Clinical Core will draw blood from participants for genetic analysis and for storage of DMA, plasma and serum for subsequent research. It will attempt to follow all subjects to autopsy so that careful neuropathological studies can be completed, and brain tissue can be used by AD investigators. The Clinical Core will refer subjects to research studies conducted by investigators associated with the ADRC, and continue to conduct collaborative research with investigators at other ADCs, and to participate in clinical trials. The Clinical Core will contribute data to the NACC, as required.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005146-22A1
Application #
6932642
Study Section
Special Emphasis Panel (ZAG1-ZIJ-7 (J4))
Project Start
2005-04-01
Project End
2010-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
22
Fiscal Year
2005
Total Cost
$322,490
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Seddighi, Sahba; Varma, Vijay R; An, Yang et al. (2018) SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging. J Alzheimers Dis 61:401-414
Fredericks, Carolyn A; Sturm, Virginia E; Brown, Jesse A et al. (2018) Early affective changes and increased connectivity in preclinical Alzheimer's disease. Alzheimers Dement (Amst) 10:471-479
Holingue, Calliope; Wennberg, Alexandra; Berger, Slava et al. (2018) Disturbed sleep and diabetes: A potential nexus of dementia risk. Metabolism 84:85-93
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
van Bergen, Jiri M G; Li, Xu; Quevenco, Frances C et al. (2018) Low cortical iron and high entorhinal cortex volume promote cognitive functioning in the oldest-old. Neurobiol Aging 64:68-75
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Kim, Sangjune; Yun, Seung Pil; Lee, Saebom et al. (2018) GBA1 deficiency negatively affects physiological ?-synuclein tetramers and related multimers. Proc Natl Acad Sci U S A 115:798-803
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Hohman, Timothy J; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol 75:989-998

Showing the most recent 10 out of 830 publications